Gastric antral vascular ectasia

Insights on the Global Tumor Ablation Industry to 2027 - Drivers, Restraints, Opportunities & Threats - ResearchAndMarkets.com

Retrieved on: 
Monday, April 6, 2020
Surgery, Health, Oncology, Medical specialties, RTT, Medicine, Clinical medicine, Gastric antral vascular ectasia, Ablation, Pancreatic cancer, Cholangiocarcinoma, Cancer, Ectasia, Radiofrequency ablation, Targeted radiofrequency ablation

The "Tumor Ablation - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Tumor Ablation - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Tumor Ablation market accounted for $394.66 million in 2018 and is expected to reach $1,253.33 million by 2027 growing at a CAGR of 13.7% during the forecast period.
  • Tumor ablation is a minimally invasive image-guided technique used in the treatment of the tumors in the liver, kidney, soft tissue and bone.
  • Tumor ablation has primarily been used for the treatment of oesophagal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia.